A Global Clinical Study Investigating the Safety and Effectiveness of Smith and Nephew's Porous Knee System in Patients Who Need a Total Knee Replacement Due to Degenerative Arthritis, Post-traumatic Arthritis or Inflammatory Arthritis
What You Need to Know Before You Apply
What is the purpose of this trial?
A clinical trial investigating the safety and effectiveness of Smith and Nephew's FDA-approved Porous Total Knee System, which is used to replace worn away and diseased knee joints. The aim of this study is to show that most patients who receive the Porous Total Knee System have reduced pain, greater mobility and a long-lasting implant post-surgery.
Who Is on the Research Team?
Amir Kamali
Principal Investigator
Smith & Nephew, Inc.
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-Surgery Assessment
X-rays and questionnaires are administered to assess knee pain, activities of daily living, quality of life, and patient feelings about their knee
Surgery and Immediate Post-Operative Care
Patients undergo total knee replacement surgery with the Smith and Nephew Porous Total Knee System
Post-Operative Follow-up
Participants are monitored for safety and effectiveness, including radiographic assessments and patient-reported outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Porous Total Knee System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Smith & Nephew, Inc.
Lead Sponsor
Dr. Maria Berkman
Smith & Nephew, Inc.
Chief Medical Officer since 2023
MD from Harvard Medical School
Dr. Deepak Nath
Smith & Nephew, Inc.
Chief Executive Officer since 2022
PhD in Theoretical Mechanics, University of California, Berkeley